IP Library Granted Patent US 11,089,785
Granted Patent B2
US 11,089,785 · App. 16/070,703 · Granted Aug 17, 2021

Bacterial and fungal metabolites possessing anti-microbial activity against

Inventors: Fadi Dagher (Laval, CA); Eric Deziel (Rosemere, CA); Snizhana Olishevska (Montreal, CA)
Assignee: Institut National De U Recherche Scientifique
A01N63/30A01N63/10A01N63/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,089,785
App. No.
16/070,703
Granted
Aug 17, 2021
Kind
B2
Abstract

Anti-microbial metabolites secreted from various bacterial and/or fungal species are described that have anti-bacterial activity against Xanthomonas species, which cause disease in plant hosts, including a wide variety of crops. Bacterial and fungal species producing such metabolites were identified from environmental samples (seeds, different vegetable organs and soil) from different geographic locations. Compositions, methods, uses, and kits 5 relating to the identified anti-microbial metabolites are also described.

Claims (12)

1. A biopesticide having antimicrobial activity against phytopathogenic Xanthomonas species, said biopesticide consisting of Bacillus amyloliquefaciens subsp. plantarum 71 (NRRL B-67021) and metabolites thereof, and one or more agriculturally acceptable excipients, wherein said metabolites comprise polyketide metabolites bacillaene, difficidin, and macrolactin.

2. The biopesticide of claim 1 , wherein said metabolites are extracellular bacterial metabolites.

3. The biopesticide of claim 1 , wherein said biopesticide has antimicrobial activity against Xanthomonas campestris, Xanthomonas perforans, Xanthomonas gardneri , or any combination thereof.

4. The biopesticide of claim 1 , wherein said antimicrobial activity comprises antagonistic activity.

5. The biopesticide of claim 1 , wherein said metabolites comprise lipopeptides and/or siderophores having anti- Xanthomonas activity.

6. The biopesticide of claim 5 , wherein said lipopeptides are non-ribosomal lipopeptides (NRPs).

7. The biopesticide of claim 5 , wherein said lipopeptides and/or siderophores comprise surfactin, fengycin, iturin, bacilysin, and bacillibactin, or any combination thereof.

8. The biopesticide of claim 1 , wherein said metabolites further comprise bacillaene, difficidin, macrolactin, kalimantacin/batumin, plantathiazolicin/plantazolicin, and bacteriocin, or any combination thereof.

9. The biopesticide of claim 1 , wherein the agriculturally acceptable excipient comprises a non-toxic carrier, surfactant, preservatives, nutrients, UV protectant, sticker, spreader, and/or chelating agent.

10. The biopesticide of claim 1 , wherein said composition is in the form of a liquid, concentrate, powder, tablet, gel, pellets, granules, or any combination thereof.

11. A method for controlling the growth of a pathogenic microorganism on a target plant or tissue, said method comprising contacting said target plant or tissue with the biopesticide of claim 1 .

12. A method for producing the biopesticide of claim 1 , the method comprising culturing viable cells of Bacillus amyloliquefaciens subsp. plantarum 71 (NRRL B-67021) under conditions enabling the production of said metabolites; harvesting and/or concentrating said metabolites produced from said viable cells; and formulating said metabolites to produce said biopesticide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2019
From: DAGHER, FADI; DEZIEL, ÉRIC; OLISHEVSKA, SNIZHANA
To: INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 050212/0605 →
Continuity (2)
Provisional Application 62165412 · May 22, 2015
Related Publication 20190230938A1 · Aug 1, 2019